MedPath

Effect of perioperative ketamine on postoperative cognition – a randomized placebo-controlled trial

Recruiting
Conditions
postoperative cognitive decline
Registration Number
NL-OMON20273
Lead Sponsor
eiden University Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Patients planned for elective surgery lasting > 2 1 h that require postoperative pain relief will be enrolled in the study after written informed consent is obtained.

Exclusion Criteria

•age < 54 years,

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
• To assess the effect of perioperative ketamine on postoperative cognitive function on day 1 and 30 following surgery.
Secondary Outcome Measures
NameTimeMethod
• To assess the effect of perioperative ketamine on postoperative pain and perioperative analgesics consumption on days 1 and 2 following surgery and persistent pain as measured on day 30 following surgery.<br /><br>• To assess the effect of perioperative ketamine on depth of anesthesia and sedation (postoperatively) and nociceptive level during anesthesia.<br /><br>• To assess side effects during ketamine administration: hypertension, tachycardia, nausea/vomiting, psychomimetic side effects, lightheadedness/dizziness, drug high and elevated liver enzymes. <br /><br>• The assess the effect of ketamine on inflammatory marker C-reactive protein on day 1 after surgery.<br>
© Copyright 2025. All Rights Reserved by MedPath